Chen
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If Chen is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- Adaptive Oxide Switching Devices for Scalable ESD Protection in AI Driven Microelectronics · nsf · 2026-10-15 · usually covers Federal Alignment
- Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM) · PR Newswire — All News Releases · 2026-09-03 · usually covers Deal Primary
- GLP-1 agonist semaglutide slows aging in mice · Chemical & Engineering News · 2026-09-03 · usually covers Chemicals
- GLP-1 Drug Semaglutide Slows Aging and Extends Lifespan in Mice · GEN - Genetic Engineering & Biotechnology News · 2026-09-03 · usually covers Auto
- When Edge AI Lies: Fault Injection and False State in Live Perception Pipelines · Semiconductor Engineering · 2026-09-02 · usually covers Artificial Intelligence
- U.S. Diesel Prices Close In on April War Peak · Oil Price · 2026-09-02 · usually covers Energy
What the reporting says
It shows up alongside Colorectal Cancer (46), Immunotherapy (18), AI (35), Wang (12), China (17), David (16), Google (16), Nvidia (15).
Two steps out: Braf (through Colorectal Cancer, 46 shared stories on the weaker link); ctDNA (through Colorectal Cancer, 46 shared stories on the weaker link); Egfr (through Colorectal Cancer, 46 shared stories on the weaker link); KRAS (through Colorectal Cancer, 46 shared stories on the weaker link).
Tracked since Jan 1, with coverage on 42 separate days — concentrated in Pubmed Targeted.